Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Gene | APC |
Variant | S811* |
Impact List | nonsense |
Protein Effect | loss of function |
Gene Variant Descriptions | APC S811* results in a premature truncation of the Apc protein at amino acid 811 of 2843 (UniProt.org). S811* retains binding with Axin1 and Beta-catenin in culture but results in decreased Beta-catenin phosphorylation and ubiquitylation (PMID: 34352208) and loss of the 20-amino acid repeats of Apc involved in degradation of Beta-catenin and leads to TCF/LEF activity in culture (PMID: 28179481). |
Associated Drug Resistance | |
Category Variants Paths |
APC mutant APC inact mut APC S811* |
Transcript | NM_000038.5 |
gDNA | chr5:g.112838026C>A |
cDNA | c.2432C>A |
Protein | p.S811* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001127510 | chr5:g.112838026C>A | c.2432C>A | p.S811* | RefSeq | GRCh38/hg38 |
NM_000038 | chr5:g.112838026C>A | c.2432C>A | p.S811* | RefSeq | GRCh38/hg38 |
NM_001354895.1 | chr5:g.112838026C>A | c.2432C>A | p.S811* | RefSeq | GRCh38/hg38 |
NM_001127510.2 | chr5:g.112838026C>A | c.2432C>A | p.S811* | RefSeq | GRCh38/hg38 |
NM_000038.5 | chr5:g.112838026C>A | c.2432C>A | p.S811* | RefSeq | GRCh38/hg38 |
NM_001354898.1 | chr5:g.112838101C>A | c.2432C>A | p.S811* | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
APC S811* | colorectal cancer | sensitive | G007-LK | Preclinical - Cell culture | Actionable | In a preclinical study, treatment with G007-LK decreased active beta-catenin levels and Tcf/LEF activity, and reduced growth of a colorectal cancer cell line harboring APC S811* in culture (PMID: 28179481). | 28179481 |
APC S811* | colorectal cancer | sensitive | IWR-1 | Preclinical - Cell culture | Actionable | In a preclinical study, treatment with IWR-1 decreased active beta-catenin levels and reduced growth of a colorectal cancer cell line harboring APC S811* in culture (PMID: 28179481). | 28179481 |
APC S811* | colorectal cancer | sensitive | XAV939 | Preclinical - Cell culture | Actionable | In a preclinical study, XAV939 inhibited growth of a colorectal cancer cell line harboring APC S811* in culture (PMID: 28179481). | 28179481 |
APC S811* | colorectal cancer | sensitive | STP1002 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, STP1002 inhibited Wnt/beta-catenin signaling and colony formation in colorectal cancer cell lines harboring APC S811* in culture and inhibited tumor growth in a cell line xenograft model (PMID: 35849876). | 35849876 |